Skip to main content
. 2024 Nov 24;30(11):e70129. doi: 10.1111/cns.70129

TABLE 1.

Demographic and clinical characteristics.

Variables FBTCS− (n = 37) FBTCS+ (n = 89) HC (n = 60) p
Age, median [IQR], years 25 [21, 28] 25 [22, 31] 24 [20, 29] 0.209*
Gender, n (%) 0.243 #
Male 17 (45.9) 51 (57.3) 38 (63.3)
Female 20 (54.1) 38 (42.7) 22 (36.7)
TIV, median [IQR], cm3 1465.20 [1360.96, 1556.85] 1480.50 [1411.39, 1602.28] 1534.40 [1445.34, 1644.40] 0.075*
Lateralization, n (%) 0.936 #
Left 19 (51.4) 45 (50.6) NA
Right 18 (48.6) 44 (49.4) NA
Febrile seizure history, n (%) 0.051 #
Yes 15 (40.5) 53 (59.6) NA
No 22 (59.5) 36 (40.4) NA
Seizure frequency, n (%) 0.704 #
Frequent 19 (27.9) 49 (72.1) NA
Infrequent 18 (31.0) 40 (69.0) NA
Seizure onset age, median [IQR], years 15 [9, 18] 14 [8, 18] NA 0.332 §
Duration, median [IQR], years 10 [6, 14] 12 [7, 17] NA 0.155 §

Abbreviations: FBTCS−, without focal to bilateral tonic–clonic seizures; FBTCS+, with focal to bilateral tonic–clonic seizures; HC, healthy control; IQR, interquartile range; TIV, total intracranial volume.

*

Kruskal–Wallis H test.

#

Chi‐square test.

§

Mann–Whitney U test.